Zobrazeno 1 - 10
of 484
pro vyhledávání: '"Paubelle E"'
Autor:
Zylbersztejn F; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France.; Necker Hospital, Imagine Institute, Inserm U116 CNRS ERL 8654, 75015, Paris, France., Byelinska I; Department of Clinical Medicine, Educational and Scientific Center 'Institute of Biology and Medicine', Taras Shevchenko National University of Kyiv, Kyiv, Ukraine., Jeanpierre S; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France.; Centre Léon Bérard, 69000, Lyon, France., Barral L; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France., Geistlich K; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France.; Necker Hospital, Imagine Institute, Inserm U116 CNRS ERL 8654, 75015, Paris, France., Flores-Violante M; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France., Voeltzel T; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France., Paubelle E; Hospices Civils de Lyon, Hematology Department, Centre Hospitalier Lyon Sud, 69495, Pierre Bénite, France., Heiblig M; Hospices Civils de Lyon, Hematology Department, Centre Hospitalier Lyon Sud, 69495, Pierre Bénite, France., Alcazer V; Hospices Civils de Lyon, Hematology Department, Centre Hospitalier Lyon Sud, 69495, Pierre Bénite, France., Le Meur G; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France.; Hospices Civils de Lyon, Hematology Department, Centre Hospitalier Lyon Sud, 69495, Pierre Bénite, France., Fossard G; Hospices Civils de Lyon, Hematology Department, Centre Hospitalier Lyon Sud, 69495, Pierre Bénite, France., Belhabri A; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France.; Centre Léon Bérard, 69000, Lyon, France., Cruz-Moura I; Necker Hospital, Imagine Institute, Inserm U116 CNRS ERL 8654, 75015, Paris, France., Hermine O; Necker Hospital, Imagine Institute, Inserm U116 CNRS ERL 8654, 75015, Paris, France., Lefort S; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France. sylvain.lefort@lyon.unicancer.fr.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France. sylvain.lefort@lyon.unicancer.fr.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France. sylvain.lefort@lyon.unicancer.fr.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France. sylvain.lefort@lyon.unicancer.fr., Maguer-Satta V; CNRS UMR5286, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France. veronique.maguer-satta@lyon.unicancer.fr.; Inserm U1052, Centre de Recherche en Cancérologie de Lyon, 69000, Lyon, France. veronique.maguer-satta@lyon.unicancer.fr.; Department of Cancer Initiation and Tumor Cell Identity, Lyon, France. veronique.maguer-satta@lyon.unicancer.fr.; Université Claude Bernard Lyon 1, CRCL, 69000, Lyon, France. veronique.maguer-satta@lyon.unicancer.fr.; Centre Léon Bérard, 69000, Lyon, France. veronique.maguer-satta@lyon.unicancer.fr.
Publikováno v:
Cell death discovery [Cell Death Discov] 2024 Jul 16; Vol. 10 (1), pp. 325. Date of Electronic Publication: 2024 Jul 16.
Autor:
Djordjevic S; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France., Itzykson R; Département Hématologie et Immunologie, Hôpital Saint-Louis, Assistance Publique-Hôpitaux de Paris, France.; Génomes, Biologie Cellulaire et Thérapeutique U944, INSERM, CNRS, Université Paris Cité, France., Hague F; Laboratoire de Physiologie Cellulaire et Moléculaire UR4667, Université Picardie Jules Verne, Amiens, France., Lebon D; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.; Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens-Picardie, France., Legrand J; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France., Ouled-Haddou H; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France., Jedraszak G; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.; Laboratoire de Génétique Constitutionnelle, CHU Amiens-Picardie, France., Harbonnier J; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France., Collet L; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France., Paubelle E; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.; Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens-Picardie, France., Marolleau JP; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.; Service d'Hématologie Clinique et de Thérapie Cellulaire, CHU Amiens-Picardie, France., Garçon L; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.; Service d'Hématologie Biologique, CHU Amiens-Picardie, France., Boyer T; HEMATIM UR4666, Université Picardie Jules Verne, Amiens, France.; Service d'Hématologie Biologique, CHU Amiens-Picardie, France.
Publikováno v:
Molecular oncology [Mol Oncol] 2024 Jun; Vol. 18 (6), pp. 1571-1592. Date of Electronic Publication: 2024 Jan 17.
Autor:
Durand G; Department of Haematology and Histocompatibility, Amiens University Hospital, Amiens, France.; EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France., Desoutter J; Department of Haematology and Histocompatibility, Amiens University Hospital, Amiens, France.; EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France., Lorriaux C; Department of Blood Transfusions, Amiens University Hospital, Amiens, France., Poumaredes G; Department of Biology, Etablissement Français du Sang (EFS) Hauts de France, Amiens, France., Joris M; Department of Clinical Haematology and Cellular Therapy, Amiens University Hospital, Amiens, France., Charbonnier A; Department of Clinical Haematology and Cellular Therapy, Amiens University Hospital, Amiens, France., Lebon D; EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France.; Department of Clinical Haematology and Cellular Therapy, Amiens University Hospital, Amiens, France., Paubelle E; EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France.; Department of Clinical Haematology and Cellular Therapy, Amiens University Hospital, Amiens, France., Garcon L; Department of Haematology and Histocompatibility, Amiens University Hospital, Amiens, France.; EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France., Guillaume N; Department of Haematology and Histocompatibility, Amiens University Hospital, Amiens, France.; EA HEMATIM 4666, Jules Verne University of Picardie, Amiens, France.
Publikováno v:
HLA [HLA] 2024 Mar; Vol. 103 (3), pp. e15438.
Autor:
Marolleau P; Medical Oncology Department, Leon Berard Center, Lyon, France., Tougeron D; Gastroenterology and Hepatology Department, Poitiers University Hospital, University of Poitiers, Poitiers, France., Allignet B; Department of Radiation Oncology, Leon Berard Center, Lyon, France., Cohen R; Department of Medical Oncology, Saint-Antoine Hospital, Sorbonne Université, AP-HP, and INSERM, Unité Mixte de Recherche Scientifique 938, Centre de Recherche Saint-Antoine, Equipe Instabilité des Microsatellites et Cancer, Equipe labellisée par la Ligue Nationale contre le Cancer, Paris, France., Sefrioui D; Normandy Centre for Genomic and Personalized Medicine and Department of Hepatogastroenterology, Normandie Univ, UNIROUEN, Inserm U1245, IRON group, Rouen University Hospital, Rouen, France., Gallet B; Department of Medical Oncology, Val d'Aurelle Center, Montpellier, France., Dumont F; Department of Surgical Oncology, Comprehensive Cancer Center, Institut de Cancérologie de l'Ouest, France., Guimbaud R; Digestive Oncology Department, Rangueil Hospital, University Hospital of Toulouse, France., Alouani E; Digestive Oncology Department, Rangueil Hospital, University Hospital of Toulouse, France., Passot G; Department of General Surgery and Surgical Oncology, Centre Hospitalier Lyon-Sud, Hospices Civils de Lyon, Pierre-Bénite, France., Desolneux G; Department of Surgical Oncology, Bergonie Institute, Bordeaux, France., Ghiringhelli F; Department of Medical Oncology, GF Leclerc Center, Dijon, France., Marchal F; Department of Surgical Oncology, Lorraine Cancer Center, Vandoeuvre les Nancy, France., Mourthadhoi F; Department of General Surgery, Saint Etienne University Hospital, Jean Monnet University, Saint Etienne, France., Coriat R; Gastroenterology Department, Cochin University Hospital, Université de Paris, APHP, Paris, France., Desgrippes R; Gastroenterology Department, Saint Malo General Hospital, Saint Malo, France., Locher C; Gastroenterology and Digestive Oncology Department, Meaux Hospital, Meaux, France., Goujon G; Gastroenterology Department, Bichat Hospital, Paris, France., Des Guetz G; Gastroenterology Department, Bichat Hospital, Paris, France., Aparicio T; Gastroenterology Department, Saint Louis Hospital, Paris, France., Paubelle E; Hematology Department, Amiens University Hospital, Amiens, France., Dupré A; Surgical Department, Centre Léon Bérard, Lyon, France., de la Fouchardière C; Medical Oncology Department, Leon Berard Center, Lyon, France.; Medical Oncology Department, Institut Paoli-Calmettes, Marseille, France.
Publikováno v:
International journal of cancer [Int J Cancer] 2023 Oct 01; Vol. 153 (7), pp. 1376-1385. Date of Electronic Publication: 2023 Jul 05.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Kerneves P; Laboratoire d'Hématologie Biologique, CHU de Caen, Caen, France., Cornet E; Laboratoire d'Hématologie Biologique, CHU de Caen, Caen, France., Paubelle E; Institut d'Hématologie de Basse-Normandie, CHU de Caen, Caen, France.; INSERM UMR-S U1237, Physiopathology and Imaging of Neurological Disorders, GIP Cyceron, Institut Blood and Brain @ Caen-Normandie (BB@C), Caen, France.
Publikováno v:
International journal of laboratory hematology [Int J Lab Hematol] 2021 Oct; Vol. 43 (5), pp. 890-891. Date of Electronic Publication: 2021 Feb 15.
Autor:
Malard F; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France. florent.malard@inserm.fr., Vekhoff A; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France., Lapusan S; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France., Isnard F; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France., D'incan-Corda E; Service d'hématologie, Institut Paoli Calmettes, Marseille, France., Rey J; Service d'hématologie, Institut Paoli Calmettes, Marseille, France., Saillard C; Service d'hématologie, Institut Paoli Calmettes, Marseille, France., Thomas X; Service d'hématologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Ducastelle-Lepretre S; Service d'hématologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Paubelle E; Service d'hématologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Larcher MV; Service d'hématologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Rocher C; Service d'hématologie, Centre Hospitalier Lyon Sud, Hospices Civils de Lyon, Lyon, France., Recher C; CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse III Paul Sabatier, Service d'hématologie, Toulouse, France., Tavitian S; CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse III Paul Sabatier, Service d'hématologie, Toulouse, France., Bertoli S; CHU de Toulouse, Institut Universitaire du Cancer de Toulouse Oncopole, Université de Toulouse III Paul Sabatier, Service d'hématologie, Toulouse, France., Michallet AS; Service d'hématologie, Centre Léon Bérard, Lyon, France., Gilis L; Service d'hématologie, Centre Léon Bérard, Lyon, France., Peterlin P; Service d'hématologie, CHU Nantes, Nantes, France., Chevallier P; Service d'hématologie, CHU Nantes, Nantes, France., Nguyen S; Service d'hématologie clinique, Hôpital de la Pitié Salpétrière, APHP, Sorbonne Université, Paris, France., Plantamura E; MaaT Pharma, Lyon, France., Boucinha L; MaaT Pharma, Lyon, France., Gasc C; MaaT Pharma, Lyon, France., Michallet M; Service d'hématologie, Centre Léon Bérard, Lyon, France., Dore J; Université Paris-Saclay, INRAE, MetaGenoPolis, AgroParisTech, MICALIS, Jouy-en-Josas, France., Legrand O; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France., Mohty M; Service d'hématologie clinique et de thérapie cellulaire, Hôpital Saint Antoine, APHP, Sorbonne Université, INSERM UMRs 938, Paris, France.
Publikováno v:
Nature communications [Nat Commun] 2021 May 25; Vol. 12 (1), pp. 3084. Date of Electronic Publication: 2021 May 25.
Akademický článek
Tento výsledek nelze pro nepřihlášené uživatele zobrazit.
K zobrazení výsledku je třeba se přihlásit.
K zobrazení výsledku je třeba se přihlásit.
Autor:
Paubelle E; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France; CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, 75015 Paris, France. Electronic address: paubelle-e@chu-caen.fr., Zylbersztejn F; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France; CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France., Maciel TT; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France., Carvalho C; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France., Mupo A; Haematological Cancer Genetics, Wellcome Trust Genome Campus, Wellcome Trust Sanger Institute, Hinxton Cambridge CB10 1SA, UK., Cheok M; Centre of Research Jean-Pierre Aubert, INSERM UMR 837, 59000 Lille, France., Lieben L; Laboratory of Experimental Medicine and Endocrinology, KU Leuven 3000, Belgium., Sujobert P; Institut Cochin, Département d'Immuno-Hématologie, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, INSERM U1016 Paris, France; Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France., Decroocq J; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France; CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France., Yokoyama A; National Cancer Center Research Institute, Chiba 277-8577, Japan., Asnafi V; Department of Biological Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, 75015 Paris, France., Macintyre E; Department of Biological Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, 75015 Paris, France., Tamburini J; Institut Cochin, Département d'Immuno-Hématologie, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, INSERM U1016 Paris, France; Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France., Bardet V; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France; CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France., Castaigne S; Department of Hematology, Hôpital Mignot, 78150 Le Chesnay, France., Preudhomme C; Centre of Research Jean-Pierre Aubert, INSERM UMR 837, 59000 Lille, France., Dombret H; Department of Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Saint-Louis, 75010 Paris, France., Carmeliet G; Laboratory of Experimental Medicine and Endocrinology, KU Leuven 3000, Belgium., Bouscary D; Institut Cochin, Département d'Immuno-Hématologie, Centre National de la Recherche Scientifique (CNRS), Unité Mixte de Recherche (UMR) 8104, INSERM U1016 Paris, France; Université Paris Descartes, Faculté de Médecine Sorbonne Paris Cité, Paris, France; Equipe Labellisée Ligue Nationale Contre le Cancer (LNCC), Paris, France., Ginzburg YZ; Erythropoiesis Laboratory, LFKRI, New York Blood Center, New York, NY, USA., de Thé H; Molecular Virology and Pathology, INSERM UMR 944, 75010 Paris, France; Molecular Virology and Pathology, CNRS 7212, 75010 Paris, France., Benhamou M; INSERM U1149, Center for Research on Inflammation, 75018 Paris, France., Monteiro RC; INSERM U1149, Center for Research on Inflammation, 75018 Paris, France., Vassiliou GS; Haematological Cancer Genetics, Wellcome Trust Genome Campus, Wellcome Trust Sanger Institute, Hinxton Cambridge CB10 1SA, UK., Hermine O; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France; CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Department of Clinical Hematology, Assistance Publique-Hôpitaux de Paris, Hôpital Necker, 75015 Paris, France; Laboratory of Excellence GR-Ex, 75015 Paris, France. Electronic address: ohermine@gmail.com., Moura IC; INSERM UMR 1163, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Paris Descartes - Sorbonne Paris Cité University, Imagine Institute, 75015 Paris, France; CNRS ERL 8254, Laboratory of Cellular and Molecular Mechanisms of Hematological Disorders and Therapeutical Implications, 75015 Paris, France; Laboratory of Excellence GR-Ex, 75015 Paris, France.
Publikováno v:
Cell reports [Cell Rep] 2020 Jan 21; Vol. 30 (3), pp. 739-754.e4.
Efficacy of All-Trans-Retinoic Acid in High-Risk Acute Myeloid Leukemia with Overexpression of EVI1.
Autor:
Paubelle E; Department of Clinical Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France.; Faculté de Médecine Lyon-Sud Charles Mérieux, Université de Lyon, Pierre Bénite, France.; Laboratoire de Biologie et Modélisation de la Cellule, CNRS UMR5239, Faculté de Médecine Lyon-Sud, Ecole Normale supérieure de Lyon, Hospices Civils de Lyon, Pierre Bénite, France., Plesa A; Department of Biological Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Hayette S; Department of Biological Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre-Bénite, France., Elhamri M; Department of Clinical Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France., Zylbersztejn F; Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, Imagine Institute, Paris, France., Hermine O; Laboratory of Molecular Mechanisms of Hematologic Disorders and Therapeutic Implications, Imagine Institute, Paris, France.; Department of Clinical Hematology, Hôpital Necker-Enfants-Malades, Paris, France., Salles G; Department of Clinical Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France., Thomas X; Department of Clinical Hematology, Hospices Civils de Lyon, Centre Hospitalier Lyon-Sud, Pierre Bénite, France. xavier.thomas@chu-lyon.fr.
Publikováno v:
Oncology and therapy [Oncol Ther] 2019 Dec; Vol. 7 (2), pp. 121-130. Date of Electronic Publication: 2019 May 22.